Stefan G. Burdach

Munich, BY 80804, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors.

Proinflammatory signaling in Ewing sarcoma is driven by retroelement activity and counteracted by reverse transcriptase inhibitors.

Journal: Cell reports

Published: October 30, 2025

Potential biomarkers of Ewing sarcoma identified through a Europe-wide analysis of prospectively collected samples.

Potential biomarkers of Ewing sarcoma identified through a Europe-wide analysis of prospectively collected samples.

Journal: Scientific reports

Published: October 29, 2025

TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model.

TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model.

Journal: Frontiers in immunology

Published: October 31, 2023

Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.

Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 13, 2023

Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma.

Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma.

Journal: Cancers

Published: November 30, 2022

Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma.

Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma.

Journal: Cancers

Published: October 18, 2022

T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer.

T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer.

Journal: Cancers

Published: October 08, 2022

The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.

The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 12, 2022

High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.

High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 15, 2022

Correction to: Precision medicine in pediatric oncology.

Correction to: Precision medicine in pediatric oncology.

Journal: Molecular and cellular pediatrics

Published: March 10, 2022

No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.

No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.

Journal: Frontiers in oncology

Published: February 17, 2022

Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.

Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 04, 2022

Showing 1-12 of 83

Last Updated: 09/26/2026